Change of Anti-HCV Antibody Titer During Interferon Therapy. Investigation of NS3, NS4 and Core Region Antibody.

Acta Hepatologica Japonica- Japan

doi 10.2957/kanzo.34.198

Full Text

Abstract

Available in

Categories

Hepatology

Date

Authors

Publisher

Japan Society of Hepatology

Related search

HIV Neutralizing Antibody Titer During Structured Treatment Interruption of Highly Active Antiretroviral Therapy

AIDS
Infectious DiseasesAllergyImmunology
2012English

An Availability of HCV-core Antibody determination.The Study in HCV Antibody Electropositive Case in a Mass Examination.

Acta Hepatologica Japonica
Hepatology
1993English

Anti-HCV Prevalence in Medical Employees Using Different HCV Antibody Kits.

Journal of the Japan Society of Blood Transfusion
1992English

Anti-Myostatin Antibody Therapy for Myopathies

Clinical Neurology
Neurology
2011English

The Synergistic Antitumor Effect of Combined Anti-Human Epidermal Growth Factor Receptor 2 Antibody and Gamma Interferon Therapy on Antibody-Resistant Breast Cancer Cells

The Showa University Journal of Medical Sciences
2019English

Anti-HCV Antibody Positivity Among Voluntary Blood Donors With Transfusion Histories.

Journal of the Japan Society of Blood Transfusion
1991English

Equine Antihapten Antibody: The Subunits and Fragments of Anti- -Lactoside Antibody

Journal of Experimental Medicine
MedicineAllergyImmunology
1967English

Vertical HIV-1 Transmission: Importance of Neutralizing Antibody Titer and Specificity

Scandinavian Journal of Immunology
MedicineImmunology
2001English

Principles of Antibody Therapy.

BMJ
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy